Antibody Titers Following the HPV4 Series Administered at Delayed Dosing Intervals

Emmanuel Walter, MD, MPH1, Rowena Dolor, MD, MHS2, Alex Kemper, MD, MPH, MS1, Elizabeth Unger, Ph.D., MD3, Gitika Panicker, Ph.D.3, Kate Russell, MD, MPH1, Lauri Markowitz, MD4 and Eileen Dunne, MD, MPH5, 1Department of Pediatrics, Duke University School of Medicine, Durham, NC, 2Department of Medicine, Duke University School of Medicine, Durham, NC, 3Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, GA, 4Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, 5Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA

© 2014, Centers for Disease Control and Prevention
2014 National STD Prevention Conference